The Institute of Cancer Research, London, is one of the world's most influential cancer research organisations, with an outstanding record of achievement.

The Royal Marsden NHS Foundation Trust is a world-leading specialist cancer hospital. The Institute of Cancer Research works in close partnership with The Royal Marsden to take the results of our ...

We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

The Centre for Cancer Drug Discovery at The Institute of Cancer Research, London, is the largest academic cancer drug discovery and development group worldwide. Its research groups cover every aspect ...

The Adult Drug Development Unit (DDU) at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, comprises an internationally-leading group of >100 staff focused on early ...

Our leadership teamProfessor Kristian Helin Chief Executive and President The Chief Executive is responsible to the Board of Trustees for the overall direction of the ICR’s management, research and ...

The ICR is an exempt charity – reference number X90004. We are also a college of the University of London and adhere to regulations as set by the Office for Students and Research England.

‘Be part of it’, our strategic plan to engage with our local communities, inspire future diversity in science, and continue to create an environment where public engagement can thrive. The strategy ...

A new genetically engineered virus has delivered a one-two punch against advanced cancers in initial findings from a phase I trial. Researchers found that RP2 – a modified version of the herpes ...

Professor Clare Isacke aims to identify the processes by which tumour cells recruit non-cancerous cells during metastasis. She has held several senior positions at the ICR, including acting as Interim ...

The ICR-CTSU manages a number of trials in different disease sites. View the trials below, ordered by enrolment status. ATARI investigates whether a new type of drug could help treat people with ...

The division is focused on identifying both the genetic and environmental causes of breast cancer, so we can improve diagnosis, assess prognosis and likely response to treatment more accurately, and ...